tiaramide has been researched along with cromolyn sodium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashii, H; Horiba, M; Matsubara, S; Nabe, T; Ohata, K; Watanabe-Kohno, S; Yamamura, H; Yasui, K | 1 |
| Coutts, S; Khandwala, A; Weinryb, I | 1 |
| Mikawa, K | 1 |
1 trial(s) available for tiaramide and cromolyn sodium
| Article | Year |
|---|---|
Clinical practice and drug therapy on pediatric bronchial asthma in Japan.
Topics: Adult; Asthma; Benzothiazoles; Bronchodilator Agents; Child; Child, Preschool; Clinical Trials as Topic; Cromolyn Sodium; Double-Blind Method; Humans; Japan; Piperazines; Sympathomimetics | 1981 |
2 other study(ies) available for tiaramide and cromolyn sodium
| Article | Year |
|---|---|
A tiaramide derivative, 5-chloro-3-(4-hydroxypiperadinocarbonylmethyl)benzothiazoline-2-one (HPR-611), a potent inhibitor of anaphylactic chemical mediator release--a distinctive feature from disodium cromoglycate.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzothiazoles; Cromolyn Sodium; Female; Guinea Pigs; Histamine Release; Humans; Leukotrienes; Lung; Mast Cells; Peritoneal Cavity; Piperazines; Piperidines; Rats; Thiazoles | 1992 |
Antiallergic activity of tiaramide (RHC 2592-A).
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Basophils; Benzothiazoles; Chromones; Cromolyn Sodium; Histamine H1 Antagonists; Histamine Release; Hypersensitivity; In Vitro Techniques; Lung; Mast Cells; Piperazines; Rats | 1982 |